All In Biotech

Drug Trial Radar · NCT02479347

Wound Infections in Breast Cancer Surgery After Preoperative Skin Preparation With Chlorhexidine vs. Povidone-iodine

A Randomized, Blinded, Single Center Study to Assess the Incidence of Surgical Site Infections in Breast Cancer Surgery After Preoperative Skin Preparation With Chlorhexidine 2% in Alcohol 70% (CHLORAPREP ®) Versus 10% Povidone-iodine

Last checked: Nov 19, 2026Latest source record: Sep 9, 2021 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 2,158 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

2,158

Actual

Start

Mar 2013

Primary completion

Sep 2016

Study completion Sep 2016

Sponsor

Lead sponsor
Fondazione IRCCS Istituto Nazionale dei Tumori, MilanoAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Jun 24, 2015

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, investigator, outcomes assessor)
Primary purpose
Prevention
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The development of surgical site infections (SSI) in clean-contaminated surgery is regarded as being preventable. Known to be effective in the prevention of surgical site infection are the adequate sterilization of the surgical instruments, asepsis during operation, antibiotic prophylaxis where indicated, and certainly the preparation of the skin at the incision site, since the patient's skin is the principal source of bacterial contamination of the wound. This study aims to investigate the efficacy in prevention of surgical site infection in clean surgery, using two different standardized methods of skin preparation: povidone-iodine 10% aqueous solution from 1.5 liter bulk bottle, versus tinted 2% chlorhexidine in 70% isopropyl alcohol in a single-dose applicator. To reduce the variables involved, a single-center study will enroll a homogeneous population, undergoing breast cancer surgery.

Conditions

  • Wound Infection
  • Breast Neoplasms

Interventions

  • ChlorhexidineDrug

    Preoperative skin preparation with tinted chlorhexidine gluconate 2% in 70% isopropyl alcohol administered with single-dose applicator

  • Povidone-IodineDrug

    Preoperative skin preparation with povidone-iodine 10% aqueous solution

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Incidence of wound infection after surgery (composite outcome)Time frame: 30 days after surgery without breast implant and 180 days after surgery with implant

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Fondazione IRCCS Istituto Nazionale dei Tumori

    Milan, Mi, Italy

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.